These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1172 related articles for article (PubMed ID: 18617762)

  • 21. Clinical, laboratory, and hemodynamic parameters in portal hypertensive gastropathy: a study of 254 cirrhotics.
    Kumar A; Mishra SR; Sharma P; Sharma BC; Sarin SK
    J Clin Gastroenterol; 2010 Apr; 44(4):294-300. PubMed ID: 19730114
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Histological subclassification of cirrhosis using the Laennec fibrosis scoring system correlates with clinical stage and grade of portal hypertension.
    Kim MY; Cho MY; Baik SK; Park HJ; Jeon HK; Im CK; Won CS; Kim JW; Kim HS; Kwon SO; Eom MS; Cha SH; Kim YJ; Chang SJ; Lee SS
    J Hepatol; 2011 Nov; 55(5):1004-9. PubMed ID: 21354227
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of patients with decompensated cirrhosis at high risk for death: improving the prediction by hepatic venous pressure gradient?
    Park SH; Park HY; Kang JW; Park JS; Shin KJ; Kim CH; Suk KT; Baik GH; Kim JB; Kim DJ; Lee HY
    Hepatogastroenterology; 2012; 59(120):2548-51. PubMed ID: 23178621
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Liver stiffness accurately predicts portal hypertension related complications in patients with chronic liver disease: a prospective study.
    Robic MA; Procopet B; Métivier S; Péron JM; Selves J; Vinel JP; Bureau C
    J Hepatol; 2011 Nov; 55(5):1017-24. PubMed ID: 21354450
    [TBL] [Abstract][Full Text] [Related]  

  • 25. von Willebrand factor as new noninvasive predictor of portal hypertension, decompensation and mortality in patients with liver cirrhosis.
    Ferlitsch M; Reiberger T; Hoke M; Salzl P; Schwengerer B; Ulbrich G; Payer BA; Trauner M; Peck-Radosavljevic M; Ferlitsch A
    Hepatology; 2012 Oct; 56(4):1439-47. PubMed ID: 22532296
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of hepatic venous pressure gradient and two models of end-stage liver disease for predicting the survival in patients with decompensated liver cirrhosis.
    Suk KT; Kim CH; Park SH; Sung HT; Choi JY; Han KH; Hong SH; Kim DY; Yoon JH; Kim YS; Baik GH; Kim JB; Kim DJ
    J Clin Gastroenterol; 2012; 46(10):880-6. PubMed ID: 22810110
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic venous pressure gradient to assess fibrosis and its progression after liver transplantation for HCV cirrhosis.
    Samonakis DN; Cholongitas E; Thalheimer U; Kalambokis G; Quaglia A; Triantos CK; Mela M; Manousou P; Senzolo M; Dhillon AP; Patch D; Burroughs AK
    Liver Transpl; 2007 Sep; 13(9):1305-11. PubMed ID: 17763383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic venous pressure gradient as a predictor of fibrosis in chronic liver disease because of hepatitis B virus.
    Kumar M; Kumar A; Hissar S; Jain P; Rastogi A; Kumar D; Sakhuja P; Sarin SK
    Liver Int; 2008 May; 28(5):690-8. PubMed ID: 18433395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The influence of endoscopic variceal ligation on the portal pressure gradient in cirrhotics.
    Pereira-Lima JC; Zanette M; Lopes CV; de Mattos AA
    Hepatogastroenterology; 2003; 50(49):102-6. PubMed ID: 12630002
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical significance of worsening portal hypertension during long-term medical treatment in patients with cirrhosis who had been classified as early good-responders on haemodynamic criteria.
    Merkel C; Bolognesi M; Berzigotti A; Amodio P; Cavasin L; Casarotto IM; Zoli M; Gatta A
    J Hepatol; 2010 Jan; 52(1):45-53. PubMed ID: 19914730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Liver stiffness measurement as a predictive tool of clinically significant portal hypertension in patients with compensated hepatitis C virus or alcohol-related cirrhosis.
    Lemoine M; Katsahian S; Ziol M; Nahon P; Ganne-Carrie N; Kazemi F; Grando-Lemaire V; Trinchet JC; Beaugrand M
    Aliment Pharmacol Ther; 2008 Nov; 28(9):1102-10. PubMed ID: 18691352
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of MELD, HVPG, and their changes to predict clinically relevant endpoints in cirrhosis.
    Ripoll C; Lastra P; Rincón D; Catalina V; Bañares R
    Scand J Gastroenterol; 2012 Feb; 47(2):204-11. PubMed ID: 22242615
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Non-invasive aspartate aminotransferase to platelet ratio index correlates well with invasive hepatic venous pressure gradient in cirrhosis.
    Kirnake V; Arora A; Sharma P; Goyal M; Chawlani R; Toshniwal J; Kumar A
    Indian J Gastroenterol; 2018 Jul; 37(4):335-341. PubMed ID: 30178093
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of ascites in compensated cirrhosis with severe portal hypertension treated with β-blockers.
    Hernández-Gea V; Aracil C; Colomo A; Garupera I; Poca M; Torras X; Miñana J; Guarner C; Villanueva C
    Am J Gastroenterol; 2012 Mar; 107(3):418-27. PubMed ID: 22334252
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hepatic venous pressure gradient and prognosis in patients with acute variceal bleeding treated with pharmacologic and endoscopic therapy.
    Abraldes JG; Villanueva C; Bañares R; Aracil C; Catalina MV; Garci A-Pagán JC; Bosch J;
    J Hepatol; 2008 Feb; 48(2):229-36. PubMed ID: 18093686
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hepatic venous pressure gradient and outcomes in cirrhosis.
    Ripoll C
    J Clin Gastroenterol; 2007; 41 Suppl 3():S330-5. PubMed ID: 17975485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between the Fibrotest and portal hypertension in patients with liver disease.
    Thabut D; Imbert-Bismut F; Cazals-Hatem D; Messous D; Muntenau M; Valla DC; Moreau R; Poynard T; Lebrec D
    Aliment Pharmacol Ther; 2007 Aug; 26(3):359-68. PubMed ID: 17635370
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Prognostic value of hepatic venous pressure gradient in patients with compensated chronic hepatitis C-related cirrhosis.
    Rincón D; Lo Iacono O; Tejedor M; Hernando A; Ripoll C; Catalina MV; Salcedo M; Matilla A; Senosiain M; Clemente G; Molinero LM; Albillos A; Bañares R
    Scand J Gastroenterol; 2013 Apr; 48(4):487-95. PubMed ID: 22871085
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Histological-hemodynamic correlation in cirrhosis-a histological classification of the severity of cirrhosis.
    Nagula S; Jain D; Groszmann RJ; Garcia-Tsao G
    J Hepatol; 2006 Jan; 44(1):111-7. PubMed ID: 16274836
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MELD score, child-pugh score, and decreased albumin as risk factors for gastric variceal bleeding.
    Soga K; Tomikashi K; Miyawaki K; Fukumoto K; Wakabayashi N; Konishi H; Mitsufuji S; Yoshida N; Kokura S; Naito Y; Kataoka K; Yoshikawa T
    Hepatogastroenterology; 2009; 56(94-95):1552-6. PubMed ID: 19950829
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 59.